chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Stomachache; diarrhea very liquid stools; Feel flu like symptoms; Achy; Chills; Very sleepy; This is a spontaneous report from a contactable Consumer, the patient. A 60-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) (at the age 60 years) via an unspecified route of administration, on the left arm, on 18Mar2021 at 13:30 as a single dose for COVID-19 immunisation. The patient medical history includes diabetes, high blood pressure, thyroid and glaucoma. Concomitant medications include Bystolic [MANUFACTURER UNKNOWN], amlodipine [MANUFACTURER UNKNOWN], synthroid [MANUFACTURER UNKNOWN], allopurinol [MANUFACTURER UNKNOWN], and spiron [MANUFACTURER UNKNOWN], for unknown indications. The patient was allergic to Pineapples, stations and ceclore. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 19Mar2021 at 10:00 AM, the patient experienced achy, chills, diarrhoea very liquid stools, flu-like symptoms, stomach-ache and very sleepy. No treatment was received to treat adverse events. The clinical outcome of the events stomach-ache, watery diarrhoea, flu-like symptoms, ache, chills, and sleepy was reported as not resolved at the time of reporting. Information about lot/batch number cannot be obtained. No further information is expected.
Stated that when she was going to bed noticed a small, hard lump where vaccine was given and that it was slightly painful. She then woke up in the middle of the night because it had become extremely painful. The next morning the bump was larger and still painful. Now, (2 days later) the bump is still large and painful. She states that it is not red or really hot, but is slightly warm. I suggested she take motrin/aleve for the pain and put an ice pack on it but to go to the dr if it becomes red, hot, or swollen.
Patient states that the spot on her left arm where she received the vaccination has been sore since 10/6/20. She thought it would be sore for a couple days but she can still feel the "prick" on her arm and her arm feels sore. She went to her doctors office to find out what to do about it and they told her to take pain medication. They told her to report this to the pharmacy where she received the immunization.
body aches, chills, fatigue, and generalized headache vaginal bleeding that started 01/27/2021 (have a Mirena and have not had menstrual bleeding in 3 + years)
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: increased (High) 103.         Relevant concomitant medications were not reported.  Company Comment: Very limited information regarding the date of vaccine administration and the start date of the event have been provided. Further information has been requested.; Sender's Comments: Very limited information regarding the date of vaccine administration and the start date of the event have been provided. Further information has been requested.
The day after receiving GARDASIL patient experienced fever of 103 degrees F for three days. Nausea, vomiting, blisters on tongue.
No additional AE reported; GARDASIL 9 was inadvertently administered to a 15 month old instead of the PREVNAR 13; GARDASIL 9 was inadvertently administered to a 15 month old instead of the PREVNAR 13; This spontaneous report was received from a physician and the patient's mother and refers to a 15 months old female patient. There was no information regarding her medical history nor concurrent conditions provided. The patient's concomitant vaccination included diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (PENTACEL).  On 18-JUN-2021, the patient was inadvertently vaccinated with a dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 mL once, lot # 1687290, expiration date 06-SEP-2022 (route of administration and anatomical location were not provided) instead of pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) for prophylaxis (wrong vaccine administered, inappropriate age at vaccine administration). No adverse event (AE) was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1687290; expirationdate: 06-SEP-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Pfizer\BioNTech Covid19 vaccine given as booster dose.  Discovered first and second vaccine dose was Moderna after vaccination administered. No adverse event reported by patient.
Erythema, warmth, and swelling at site of vaccine administration starting 1 day after vaccine administration consistent with localized immune response without infection.
21SEP95 approx 11hrs had brief self limited episode of unresponsiveness, eyes staring & then rolling upwards; also had URI; ? febrile sz vs immun rxn
Large, painful swollen lymph nodes on the side of my body that got the injection beginning the evening of the vaccine and continuing.  Noticeably large in the area of my collar bone and armpit.
I went to pharmacy and get my first dosage of Moderna vaccine for COVID19 by 11:45 am and after the first 10 minutes of the shot I started feeling a mild allergic reaction with numb sensation on the back of my mouth and at the end of my tongue. They requested me wait for a full half an hour to see how my reaction develop. After 25 mints the numbness started on my nose and a little on my face (not swellings at all only the numbness sensation).  After the half hour the numbness and pain start in the area of my arm where I was vaccinate. After 45 minutes of waiting with no more new reactions they sent me home. I arrived home by 12:45 pm and took aTylenol 650 mg and a Benadryl. By 2:00 pm the numbness of the mouth reduced and the one in the nose too. I send a note to my Primary Care who answered me back and requested me to fill inform my synths to the CDC. Around 10:00 pm the numbness tried to start again and I decide to take a Cetirizine 10 mg and went to bed. I wake up next day around 6:00 am with a strong headache and a little sensitive on my nose. I took another Tylenol 650mg around 10:00 am and after 1 hour pass no more headache or any other symptom (only the soreness and pain in the vaccine area. I'm afraid to take my second dosage. Any recommendations?
PATIENT HAD ALREADY RECEIVED AN INFLUENZA VACCINE ON 9/17/22
Pt recv vax on 9/14/98; on 9/16/98 pt exp hives &rash over trunk &extremities; tx=Cortisone injection &Benadryl PO.
Rapid heart rate immediately after; light headed for 4 days; aches for 48 hours; lethargic for 3 days; loss of appetite for 3 days; This is a spontaneous report from a contactable other hcp (patient). A 67-years-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 24Feb2021 11:30 (Lot Number: EN6200) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. on 24Feb2021 11:30 patient experienced rapid heart rate immediately after, light headed for 4 days, aches for 48 hours, lethargic for 3 days, loss of appetite for 3 days. prior vaccination and post vaccination patient did not tested for covid. Patient did not received treatment. Outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Symptoms began (72 hours) 3 days after injection: Chills--lasted for 6 hours or so; aches; headache; fever lasted 17 hours; day 4--nausea, vomiting; day 5--extremely tired; day 6 diarrhea. day 7--morning headache. day 8--fine.
Pretty much sleeping; Chills; Extremely fatigued; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Pretty much sleeping), CHILLS (Chills) and FATIGUE (Extremely fatigued) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concomitant products included METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET), GLIPIZIDE, LEVOTHYROXINE SODIUM (SYNTHROID) and ATORVASTATIN for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSOMNIA (Pretty much sleeping), CHILLS (Chills) and FATIGUE (Extremely fatigued). At the time of the report, HYPERSOMNIA (Pretty much sleeping), CHILLS (Chills) and FATIGUE (Extremely fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 05-APR-2022 and Administered after 30-day Use By Date or after manufacturer date of expiry) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 05-APR-2022 and Administered after 30-day Use By Date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccine administered to patients) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 05-APR-2022 and Administered after 30-day Use By Date or after manufacturer date of expiry) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. Reporter reported that the administration of vaccine occurred from 6-Apr-2022 to 9-Apr-2022. Patient did not experience any adverse reactions after receiving the expired vaccine. The manufacturing date of the vial was 1-Dec-2021. Vial was initially placed in refrigerator on 5-Apr-2022. The product didn't undergo any temperature excursion issue. No treatment drug details was reported. This case was linked to MOD-2022-537580, MOD-2022-538672, MOD-2022-538673, MOD-2022-538675, MOD-2022-538676, MOD-2022-538677, MOD-2022-538678, MOD-2022-538681, MOD-2022-538682, MOD-2022-538689, MOD-2022-538691, MOD-2022-538692, MOD-2022-538693, MOD-2022-538697, MOD-2022-538698, MOD-2022-538701, MOD-2022-538702, MOD-2022-538689, MOD-2022-538672, MOD-2022-538676 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 11-Apr-2022: Follow up contains patient demographics.
This spontaneous report as received from a registered pharmacist refers to a 69 year old patient of unknown gender, no obese. On 01-NOV-2013, the pharmacist administered ZOSTAVAX (lot # H016230; exp. Date: 30-NOV-2013) 0.65 ml, subcutaneous for shingles prevention to the patient, using 5/8 inch needle at 45 degree angle and contents "came streaming down patient's arm" resulting in less than full dose received. Patient received an unspecified flu shot "not long ago without any incident". At the time of the report, the patient was "doing fine". Follow up information as received from the pharmacist refers to the male patient who was a teacher. The patient was vaccinated with the first dose ZOSTAVAX at the arm at 10:00 AM on 01-NOV-2013. It was reported that part of dose ran down arm. (The patient) contact doctor and was told to revaccinate in 2 days. The patient developed an allergic reaction in 24 hours and revaccination was canceled. The patient did not require emergency room/doctor visit. The outcome of the event was unknown. Additional information is not expected.
On Thursday, September 12, 2013 I received the flu and pneumonia vaccines. That night my left arm began feeling very sore. The next morning it began to swell and became very red. The pain radiated around the whole bicep and into my underarm area. Through out the day I felt feverish and sickly. The symptoms lasted until mid-day on Saturday. Both shots were given at the same time in the same arm (left).
The same day I took vaccineon April 6, 2021, I had pelvic pain and cramping that increase over the next two. Weeks. I made a appointment with my physician. On 4/29/2021 I was examined by my physician and was told to go to the ER. I had my appendix removed ans the pathology report showed that I had a bllod clot.
Patient stated that she developed achy joints following the vaccination. She talked to her doctor about it and received a prescription for prednisone that we filled today.
chills; Fever; swollen glands; nausea; lack of sleep; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 42-years-old female non-pregnant patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EP7533), via an unspecified route of administration, administered in left arm on 07Apr2021 as DOSE 2, SINGLE (at the age of 42-years-old) for COVID-19 immunization. The patient's concomitant medical history included pineapple allergy, kiwi allergy and pecans allergy. The patient's concomitant medications were not reported. The patient's historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EN6207), via an unspecified route of administration, administered in left arm on 16Mar2021 at 17:30 hours as DOSE 1, SINGLE (at the age of 41-years-old) for COVID-19 immunization and experienced chills, fever, swollen glands, nausea, and lack of sleep. The patient took no other medications in two weeks of Pfizer vaccine. The patient had no COVID prior vaccination and was not COVID tested post vaccination. On 09Apr2021, 2 days after second vaccine, the patient experienced chills, fever, swollen glands, nausea, and lack of sleep. The events resulted in doctor or other healthcare professional office/clinic visit. The patient received no treatment for the events. The clinical outcome of the events was recovered on an unspecified date in 2021.No follow-up attempts are possible. No further information is expected.
Hives on trunk of body and on right forearm.   Appeared about four hours after the shot and treated with Benadryl. Appeared again about 18 hours after the shot and treated with Benadryl again. Itching stopped but hives were still visible.
THE DAY AFTER THE VACCINE ADMINISTRATION PATIENT STARTED WITH A RASH THAT SPREAD AND PROGRESSED AND WAS DETERMINED BY MYSELF ON 10/21/2019 TO BE A CASE OF HERPES ZOSTER (SHINGLES).
arm was a little sore; This is a spontaneous report received from contactable reporter(s) (Consumer) for a Pfizer sponsored program (005570).   A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 30Jan2021 (Batch/Lot number: unknown) as dose 1, single and administration date 06Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm was a little sore". Additional information: The patient reported already had vaccine on 30Jan2021 and 2nd vaccine 06Mar2021; arm was a little sore one day but just fine.   No follow-up attempts are needed. No further information is expected.
This is a spontaneous report from a contactable Other HCP via a Pfizer sales representative.  A 16 years old female patient of an unspecified ethnicity received the first dose of TRUMENBA (batch/lot # L13514, expiration date JUL2015) at 0.5 ml single and the second dose of MENACTRA (Sanofi Pasture, lot A5178AA), both intramuscular in the left arm, on 04FEB2016 at 1:45 PM. The patient medical history and concomitant medications were not reported. The patient received a previous dose of meningococcal vaccine at the age of 12 years old. On 04FEB2016 the patient had pain in arm, on unspecified date the patient had lot of redness in flowing discomfort in her arm and swelling. The outcome of the events was recovered. The patient was not treated for pain in arm. Follow up (07MAR2016): New information from the same Other HCP included: patient age, administration details (lot and expiration date, administration site route), vaccination history, onset date, outcome of the events. Follow-up attempts completed. No further information expected.
A drop leaked while administering; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 07-APR-2023, the patient received the 2nd dose of Shingrix. On 07-APR-2023, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: A drop leaked while administering). The outcome of the incomplete dose administered was unknown.   Additional Information: GSK receipt date: 07-Apr-2023 The patient received a drop of Shingrix leaked while administering the vaccine.  There was no information on patient or vaccine reported. The reporter did not consented to follow up. The patient received a drop of Shingrix leaked while administering the vaccine, which led to incomplete dose administered.
Information has been received from a Licensed Practical Nurse, concerning a 17 year old female patient, who on unknown dates was vaccinated with the three doses of GARDASIL (route and lot numbers not provided). It was unknown if there was concomitant therapies. The Nurse stated that the patient experienced vomiting and headache after each dose. On an unknown date, the patient went to a health center where she was initially diagnosed with "abdominal migraines", but later diagnosed as "having a reaction to GARDASIL. At the time of reporting, the patient outcome was unknown. No further information is available.
She got her vaccine, her arm was sore which is typical.  Then she started feelign totally exhausted and had brain fog.  She had pains, and still has pains all over.  Her stomach is nauseated, she is not able to eat much due to this.  She is having very bad headaches, which is not something she has on a regular basis, and taking a lot of Tylenol.  Her throat is feeling finey, sore, like the muscles are sore, they hurt.  She has a slight cough, lots of congestion every day.  She was having low grade fevers, but is not having those.  The hardest part of this is the fatigue as she is not able to get out and do it.  She's barely able to get out of bed in the morning.  She called her doctor this morning for results of blood work that was done on her kidney, liver, thyroid and some other blood work was done, and everything seemed to be alright.  She is borderline diabetic and was given some information on what she needed to do to get that under control.
The emergence of red, itchy pimples on the palms, fingers, and tips of her hands.  Painful if touched.  A few more emerged over the next two days.
NO adverse effect reported; patient was administered a dose of improperly stored PROQUAD; Route of administration: "intramuscular"; This spontaneous report as received from a medical assistant refers to a patient of unknown age. No information on patient's pertinent medical history and drug reaction or allergies was provided. Concomitant medication included sterile diluent.      On 11-OCT-2019, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S006835, expiration date 02-SEP-2020 (dose and anatomical location were not provided) intramuscularly for prophylaxis. The vaccine was diluted with sterile diluent that did not experience a temperature excursion. The vaccine underwent a temperature excursion in range of 15 Fahrenheit degrees (F) to 46 F (20.7F) for 2 hours and 8 minutes. There was a previous excursion in range 6 F to 14 F (13.8 F) for 32 minutes. The call was because of data logger.
Pt recvd 1st Engerix-B 31JUL & on 03AUG91 exp weakness in knees, aching, wouldn't hold pt up; tx ASA; f/u 12AUG91 MD feels it could be the vax as has seen it w/Recombivax;
Information has been received from a nurse concerning a female patient with no pertinent medical history and no drug reactions/allergies who on an unspecified date was vaccinated intramuscularly with the first 0.5 mL dose of GARDASIL. There was no concomitant medication. On an unspecified date, the patient experienced a rash at the injection site. There was no lab diagnostics studies performed. Unspecified medical attention was sought. On an unspecified date, the patient recovered from a rash at the injection site (that eventually cleared out). Follow-up information has been received from the nurse who reported that the female patient experienced a bump at the injection site (previously reported as a rash at the injection site). Additional information is not expected. Follow-up information has been received from the 25 year old (also reported as 26 year old) unknown race female patient who on 16-JUN-2010 at 09:30 AM was vaccinated at upper left arm with the third dose (previously was reported as first dose) of GARDASIL (LOT# 0040Z). On the same day at PM, the patient complained 2X2 bump showed up on her arm. It was stated that the patient noticed that before she went to bed. This is the second of two reports received from same source. No further information is available.
Exhaustion, Diagnosed with Epstein-Barr Virus, light headedness, fever and chills
Information has been received from a physician concerning an 18 month old male with no known drug allergies who on 06/13/2001 was vaccinated with one dose of varicella vaccine. There were no concomitant medications. On 06/22/2001, the pt developed a vesicular rash and a fever of 103 deg F. The pt sought unspecified medical attention. Upon follow-up, the physician reported that the pt had a "normal side effect of vesicular like rash, two week after receiving the vaccine." Additional info has been requested.
poofyness, itching (hives), shortness of breath, headache, dizziness when upright, joints hurt  microdosing benadryl, inhaler
Sudden, very loud ringing in ears.  It was so loud that I thought it was something outside of my home, only to realize it was coming from my ears.
Patient said they were passed out and blacked out for couple times while he was in his chair.  Patient looked disoriented and sweating.  We asked if he would require medical attention and he said yes.  We gave him water to hydrate himself.  Fire dept. came in and took a look.  He did not require hospitalization as he was fine afterwards.